IRIS acquires Davstar urinalysis line
This article was originally published in Clinica
Executive Summary
IRIS is to acquire UroHealth Systems' Davstar urinalysis line. The Davstar portfolio includes the Cen-Slide 1500 system for centrifugal urine sedimentation and the FlowStar closed urine specimen collection and dispensing cup. They will be sold by IRIS' newly-acquired Norwood, Massachusetts-based StatSpin Technologies subsidiary.
You may also be interested in...
Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says
The statement, which is part of a final rule on the 340B administrative dispute resolution process, could facilitate manufacturer efforts to seek repayments from hospitals in such cases.
The Aspirin Test For AI?
US FDA Commissioner Robert Califf tells Congress that regulators don’t have to know how artificial intelligence works in medicine, but must make very sure it actually does work.
Mary Beth Clarke, CDER Exec Programs Office Director And Generic User Fee Shepherd, Will Retire
Clarke helped launch GDUFA I and negotiate GDUFA II, chaired the CDER Executive Committee and oversaw many other programs in the US FDA’s drugs center.